Corona Remedies Ltd Quarterly Result
Corona Remedies Ltd
NSE: CORONA
Net Profit - Last Quarter
Corona Remedies Ltd Quarterly Results Key Highlights
- The revenue of Corona Remedies Ltd for the Mar '26 is ₹ 357.48 crore as compare to the Dec '25 revenue of ₹ 344.68 crore.
- This represent the growth of 3.71% The ebitda of Corona Remedies Ltd for the Mar '26 is ₹ 66.41 crore as compare to the Dec '25 ebitda of ₹ 66.32 crore.
- This represent the growth of 0.14% The net profit of Corona Remedies Ltd for the Mar '26 is ₹ 45.33 crore as compare to the Dec '25 net profit of ₹ 41.27 crore.
- This represent the growth of 9.84%.
Corona Remedies Ltd Quarterly Results Analysis
Market Price of Corona Remedies Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 15 May 2026 | 1779.1 |
| 14 May 2026 | 1783.15 |
| 13 May 2026 | 1706.05 |
| 12 May 2026 | 1627.15 |
| 11 May 2026 | 1753.2 |
| 08 May 2026 | 1712.15 |
| 07 May 2026 | 1738.3 |
| 06 May 2026 | 1746.6 |
| 05 May 2026 | 1752.55 |
| 04 May 2026 | 1731.2 |
Historical Revenue of Corona Remedies Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
Historical Revenue of Corona Remedies Ltd
Historical EBITDA of Corona Remedies Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Corona Remedies Ltd
Historical Net Profit of Corona Remedies Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Corona Remedies Ltd
Corona Remedies Ltd News Hub
Shares of Corona Remedies list in B group
The equity shares of Corona Remedies (Scrip Code: 544644) are listed effective 15 December 2025 and
Read more
15 Dec 25
Corona Remedies Q2 PAT climbs 22% YoY to Rs 52 cr
Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B
Read more
03 Jan 26
Corona Remedies gains as Q2 PAT climbs 22% YoY to Rs 52 cr
Profit before tax (PBT) increased 21.67% year on year (YoY) to Rs 69.78 crore in Q2 FY26. Earnings B
Read more
05 Jan 26
Corona Remedies spurts on market debut
The stock was listed at Rs 1,452, exhibiting a premium of 36.72% to the issue price. So far, the sto
Read more
15 Dec 25
Document
Annual Reports
N/A
Credit Ratings
N/A
Concalls
Data not available
Data not available
Popular Search
About Corona Remedies Ltd
- Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited', a private limited company, dated August 27, 2004, issued by the Assistant Registrar of Companies, Gujarat at Dadra and Nagar Haveli.
- Thereafter, Company converted into a public limited and Company name has changed to CORONA Remedies Limited'.
- A fresh certificate of incorporation, is issued by the Registrar of Companies, Central Processing Centre, Manesar, Haryana on December 16, 2024. The manufacturing facilities of the Company are located at Solan (Himachal Pradesh) and at Bhayla (Ahmedabad, Gujarat).
- The Company is engaged in manufacturing, trading and marketing of Pharmaceutical products in women's healthcare, cardio-diabeto, pain management, urology and other therapeutic areas. In 2004, Company launched the first division, and later named it as Pioneer' division in year 2010; launched Xemx (multispeciality) division in 2005.
FAQs for Quarterly Results of Corona Remedies Ltd
What key financial metrics are included in Corona Remedies Ltd's quarterly results?
When does Corona Remedies Ltd announce its quarterly results?
How does Corona Remedies Ltd's quarterly performance impact its stock price?
What is the impact of Corona Remedies Ltd's quarterly results on dividends?
Are there any special announcements usually made during Corona Remedies Ltd's quarterly results?
